Moreover, with the application of CRISPR-mediated editing and somatic cell nuclear transfer, a calf with a six-amino acid substitution in the BVDV-binding domain of CD46 has been produced, showing a markedly reduced susceptibility evidenced by the absence of clinical signs and viral infection in white blood cells [40]. This evidence concerns the gene CD46 and viral infectious disease.